SCHEMBL30424858

SCHEMBL30424858

Nc1cc2cc(-c3cn(Cc4ccc(-c5nnc(C(F)F)o5)c(F)c4)nn3)ccc2cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 6/20 0.43
▸ GSK3B P49841 8/20 0.39
▸ ROCK2 O75116 7/20 0.39
▸ CDC7 O00311 1/20 0.39
▸ AURKB Q96GD4 6/20 0.38
▸ PIM1 P11309 4/20 0.38
▸ KDR P35968 5/20 0.36
▸ TEK Q02763 4/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ EPHB4 P54760 2/20 0.35
▸ JAK2 O60674 2/20 0.35
▸ FLT3 P36888 1/20 0.35
▸ PLK4 O00444 1/20 0.35
▸ AURKA O14965 1/20 0.35
▸ CHUK O15111 1/20 0.35
▸ MAPK13 O15264 1/20 0.35
▸ DAPK3 O43293 1/20 0.35
▸ CHEK2 O96017 1/20 0.35
▸ PRKCG P05129 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25387989 1.00 HDAC6 (0.43) HDAC6GSK3BROCK2CDC7AURKB
SCHEMBL25260181 0.89 HDAC6 (0.46) HDAC6KDRTEKMEN1KMT2A
SCHEMBL30425142 0.89 HDAC6 (0.46) HDAC6KDRTEKMEN1KMT2A
SCHEMBL30425608 0.88 ROCK2 (0.38) HDAC6GSK3BROCK2CDC7AURKB
SCHEMBL25387354 0.88 ROCK2 (0.38) HDAC6GSK3BROCK2CDC7AURKB
SCHEMBL25385035 0.87 HDAC6 (0.38) HDAC6GSK3BROCK2CDC7AURKB
SCHEMBL30425075 0.87 HDAC6 (0.38) HDAC6GSK3BROCK2CDC7AURKB
SCHEMBL25388263 0.86 HDAC6 (0.47) HDAC6GSK3BROCK2CDC7AURKB
SCHEMBL30424944 0.86 HDAC6 (0.47) HDAC6GSK3BROCK2CDC7AURKB
SCHEMBL25388742 0.85 ROCK2 (0.42) HDAC6GSK3BROCK2CDC7AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116157398-B Oxadiazole-based selective histone deacetylase 6 inhibitors 意大发马克股份公司 2025-03-11 — — CN claimed
CN-116157398-A 2- (4- ((5- (benzo [ b ] thiophen-3-yl) -1H-tetrazol-1-yl) methyl) phenyl) -5- (difluoromethyl) -1,3, 4-oxadiazole derivatives and similar compounds as selective inhibitors of histone deacetylase 6 (HDAC 6) for the treatment of, for example, peripheral neuropathy 意大发马克股份公司 2023-05-23 — — CN claimed
CN-116157398-B Oxadiazole-based selective histone deacetylase 6 inhibitors 意大发马克股份公司 2025-03-11 — — CN disclosed
CN-116157398-A 2- (4- ((5- (benzo [ b ] thiophen-3-yl) -1H-tetrazol-1-yl) methyl) phenyl) -5- (difluoromethyl) -1,3, 4-oxadiazole derivatives and similar compounds as selective inhibitors of histone deacetylase 6 (HDAC 6) for the treatment of, for example, peripheral neuropathy 意大发马克股份公司 2023-05-23 — — CN disclosed
Send feedback